NestLens
Portfolio Company

Werewolf Therapeutics, Inc. (HOWL)

Overview

Developing transformative conditionally activated proinflammatory immune modulating medicines to unleash a powerful attack on cancer.

Visit website ↗View full profile on NestLens →

Related on NestLens

Last updated July 15, 2026